Go Pro

Marchex (NASDAQ:MCHX) Stock Crosses Above Two Hundred Day Moving Average - Should You Sell?

Marchex logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Marchex shares moved above their 200-day moving average, reaching $1.81 before closing at $1.77, compared with a 200-day average of $1.62.
  • Analyst sentiment remains weak: Weiss Ratings maintained a “sell (D-)” rating, while MarketBeat reports a consensus rating of “Reduce” from one Hold and one Sell recommendation.
  • The company missed quarterly expectations, reporting a $0.01 per-share loss versus an expected $0.02 profit and revenue of $11.0 million versus $11.2 million estimated. Marchex also posted negative net margin and return on equity, despite institutional investors owning 73.46% of its shares.
  • Five stocks to consider instead of Marchex.

Marchex, Inc. (NASDAQ:MCHX - Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.62 and traded as high as $1.81. Marchex shares last traded at $1.77, with a volume of 8,646 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings restated a "sell (d-)" rating on shares of Marchex in a research note on Friday, July 17th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Marchex has a consensus rating of "Reduce".

Get Our Latest Stock Report on Marchex

Marchex Stock Down 1.1%

The firm has a 50-day simple moving average of $1.70 and a 200 day simple moving average of $1.62. The company has a market cap of $78.41 million, a price-to-earnings ratio of -14.75 and a beta of 1.90.

Marchex (NASDAQ:MCHX - Get Free Report) last posted its quarterly earnings data on Wednesday, August 12th. The technology company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.03). The firm had revenue of $11.00 million during the quarter, compared to analyst estimates of $11.20 million. Marchex had a negative net margin of 12.44% and a negative return on equity of 18.25%. As a group, research analysts expect that Marchex, Inc. will post 0.01 EPS for the current year.

Institutional Trading of Marchex

A number of large investors have recently bought and sold shares of the business. Kanen Wealth Management LLC grew its position in Marchex by 4.1% during the 1st quarter. Kanen Wealth Management LLC now owns 1,300,388 shares of the technology company's stock worth $2,016,000 after purchasing an additional 50,989 shares during the last quarter. Acuitas Investments LLC purchased a new stake in shares of Marchex in the first quarter valued at about $207,000. XTX Topco Ltd acquired a new stake in shares of Marchex during the fourth quarter worth about $26,000. Manatuck Hill Partners LLC acquired a new stake in shares of Marchex during the second quarter worth about $88,000. Finally, Jane Street Group LLC acquired a new stake in shares of Marchex during the first quarter worth about $30,000. Institutional investors and hedge funds own 73.46% of the company's stock.

About Marchex

(Get Free Report)

Marchex, Inc NASDAQ: MCHX operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company's core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.

Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Marchex Right Now?

Before you consider Marchex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.

While Marchex currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines